Edition:
United States

Sun Pharmaceutical Industries Ltd (SUN.BO)

SUN.BO on Bombay Stock Exchange

528.50INR
5:19am EST
Change (% chg)

Rs7.00 (+1.34%)
Prev Close
Rs521.50
Open
Rs522.50
Day's High
Rs529.95
Day's Low
Rs522.00
Volume
229,927
Avg. Vol
494,626
52-wk High
Rs728.45
52-wk Low
Rs433.15

Latest Key Developments (Source: Significant Developments)

Sun Pharma Industries MD says no new updates on Halol; awaiting FDA re-inspection of plants‍​
Tuesday, 14 Nov 2017 08:15am EST 

Nov 14 (Reuters) - Sun Pharmaceutical Industries managing director Dilip Shanghvi says::No new updates on halol, awaiting FDA reinspection of plants‍​.  Full Article

Sun Pharma Industries says co expects performance to improve in H2 FY17-18
Tuesday, 14 Nov 2017 06:40am EST 

Nov 14 (Reuters) - Sun Pharmaceutical Industries Ltd ::Says challenging U.S. pricing environment, investments in building global specialty business hit Q2 performance‍​.Says co expects performance to gradually improve in second half of the year.  Full Article

India's Sun Pharmaceutical Industries Sept-qtr consol profit falls 59 pct
Tuesday, 14 Nov 2017 05:27am EST 

Nov 14 (Reuters) - Sun Pharmaceutical Industries Ltd ::Sept quarter consol net profit 9.12 billion rupees versus profit of 22.35 billion rupees last year.Consensus forecast for Sept quarter consol profit was 8.27 billion rupees.Sept quarter consol total revenue from operations 66.50 billion rupees versus 82.60 billion rupees last year.  Full Article

Beijing Science Sun Pharmaceutical announces change in accounting policy
Thursday, 26 Oct 2017 06:19am EDT 

Oct 26(Reuters) - Beijing Science Sun Pharmaceutical Co Ltd <300485.SZ>:Says it changes accounting policy based on accounting standards for business enterprises No. 16—government subsidies, which was disclosed by the Ministry of Finance on May 10, effective June 12.  Full Article

Sun Pharmaceutical Industries gets U.S.FDA nod for generic Coreg CR‍​
Thursday, 26 Oct 2017 04:13am EDT 

Oct 26 (Reuters) - Sun Pharmaceutical Industries Ltd ::Says gets U.S.FDA nod for generic Coreg CR‍​.  Full Article

Sun Pharmaceutical Industries says unit raises shareholding in Ranbaxy Malaysia Sdn Bhd
Thursday, 12 Oct 2017 06:40am EDT 

Oct 12 (Reuters) - Sun Pharmaceutical Industries Ltd :Unit agreed to increase shareholding in Ranbaxy Malaysia Sdn Bhd via purchase of 666,985 shares of Ranbaxy Malaysia.  Full Article

Sun Pharma Industries says U.S. FDA inspection closed at co's Dadra facility‍​
Wednesday, 11 Oct 2017 07:57am EDT 

Oct 11 (Reuters) - Sun Pharmaceutical Industries Ltd :Says U.S. FDA inspection at co's Dadra facility‍​ is closed.  Full Article

Sun Pharmaceutical Industries gets shareholders' nod for re-appointing Dilip Shangvhi as MD
Tuesday, 26 Sep 2017 05:50am EDT 

Sept 26 (Reuters) - Sun Pharmaceutical Industries Ltd ::Gets shareholders' nod for re-appointment of Dilip Shangvhi as MD.  Full Article

Sun Pharmaceutical Industries says unit gets U.S. FDA nod for new label for odomzo (sonidegib)
Tuesday, 19 Sep 2017 11:22pm EDT 

Sept 20 (Reuters) - Sun Pharmaceutical Industries Ltd :Says one of co's units received approval from U.S. FDA for new label for odomzo (sonidegib).  Full Article

Sun Pharma says co on track to achieve $300 mln synergies from Ranbaxy deal
Friday, 11 Aug 2017 09:34am EDT 

Aug 11 (Reuters) - Sun Pharmaceutical Industries Ltd ::MD Dilip Shanghvi says on track to achieve $300 million synergies from Ranbaxy deal.MD Dilip Shanghvi says some impact of synergies is being lost due to U.S. Pricing pressure.MD Dilip Shanghvi says Halol plant remeidation is complete, awaiting U.S. FDA reinspection.Exec says says price control will have some impact on the industry for the next three quarters.Exec says immediate term focus is to normalise India business post GST.Exec says competitive intensity, challenging regulatory environment, price controls will determine growth of India market.Exec says co in the process of filing tildrakizumab new drug application to U.S. FDA in Q3 2018.Exec says co expects gradual improvement in ebitda margin reaching about 20-22 percent in H2 2018.  Full Article

BRIEF-Sun Pharmaceutical Industries Reports 12.3 Percent Stake In Scpharmaceuticals As Of November 21

* SUN PHARMACEUTICAL INDUSTRIES LIMITED REPORTS 12.3 PERCENT STAKE IN SCPHARMACEUTICALS INC AS OF NOVEMBER 21 - SEC FILING‍​